EFIS is a non-profit umbrella organisation that represents 36 immunology societies in Europe. Via funding initiatives and awards, EFIS helps to support immunological research and education and strengthens scientific interaction via study groups, task forces and its triennial congress - the ECI.
4 May 2026
International Day of Immunology 2026
Day of Immunology Webinar on “Regulatory T Cells: Guardians of Immune Balance“ is now available on demand!
25 Mar 2026
2026 EJI Ita Askonas Prize awarded by EFIS: Nominations invited
Call for nominations for the 2026 EJI Ita Askonas Prize awarded by EFIS is now open!
15 Dec 2025
2025 EJI Ita Askonas Prize awarded by EFIS
Following the recommendation of the EFIS Gender & Diversity Task Force, EFIS is pleased to award Anna Christina Obenauf from the Research Institute of Molecular Pathology in Vienna with the 2025 EJI Ita Askonas Prize.
View all news
At the EFIS General Assembly held during the 2024 ECI in Dublin, the new EFIS Board was elected. Continue reading to learn more about them.
Find out more
27 May 2026
STING Activation in Dendritic Cells Enhances Antigen Presentation by Live Tumor Cells
27 May 2026
Stable β2‐Microglobulin–HLA Class I Association Reshapes the Antigenic Landscape and TCR Recognition of Cancer‐Associated Epitopes
19 May 2026
Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site
19 May 2026
The RNA‐ and DNA‐Binding Protein Y‐Box Binding Protein 1 (YB‐1) Regulates iNKT Cell Development
12 May 2026
Nur77 Is Associated With Polyfunctional Properties in Virus‐Specific Human CD8+ T Cells
No expansion of MIS-C associated TCR Vβ 21.3<sup>+</sup> T-cells in pediatric Post-COVID Condition
The vimentin-targeting monoclonal antibody hzVSF-V13 reduces TH17 cell numbers and osteoclastogenesis to attenuate rheumatoid arthritis progression
Editorial Board
Elevated cytokine and nitric oxide levels in Behçet disease: EBI-3 as a potential biomarker of vascular involvement
Disrupting adenosine triphosphate metabolism as a therapeutic strategy against lymphatic cancer progression: a review